Literature DB >> 25850337

Serial measurements of serum thyroglobulin in response to recombinant human thyrotropin stimulation.

Richard Weiss1, James Magner1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25850337      PMCID： PMC4490587          DOI： 10.1089/thy.2014.0586

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  4 in total

1.  Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system.

Authors:  R Michael Tuttle; Hernan Tala; Jatin Shah; Rebecca Leboeuf; Ronald Ghossein; Mithat Gonen; Matvey Brokhin; Gal Omry; James A Fagin; Ashok Shaha
Journal:  Thyroid       Date:  2010-10-29       Impact factor: 6.568

2.  Does an undetectable rhTSH-stimulated Tg level 12 months after initial treatment of thyroid cancer indicate remission?

Authors:  Joanna Klubo-Gwiezdzinska; Kenneth D Burman; Douglas Van Nostrand; Leonard Wartofsky
Journal:  Clin Endocrinol (Oxf)       Date:  2011-01       Impact factor: 3.478

3.  A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer.

Authors:  B R Haugen; F Pacini; C Reiners; M Schlumberger; P W Ladenson; S I Sherman; D S Cooper; K E Graham; L E Braverman; M C Skarulis; T F Davies; L J DeGroot; E L Mazzaferri; G H Daniels; D S Ross; M Luster; M H Samuels; D V Becker; H R Maxon; R R Cavalieri; C A Spencer; K McEllin; B D Weintraub; E C Ridgway
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

Review 4.  Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper.

Authors:  Luca Giovanella; Penelope M Clark; Luca Chiovato; Leonidas Duntas; Rossella Elisei; Ulla Feldt-Rasmussen; Laurence Leenhardt; Markus Luster; Camilla Schalin-Jäntti; Matthias Schott; Ettore Seregni; Herald Rimmele; Jan Smit; Frederik A Verburg
Journal:  Eur J Endocrinol       Date:  2014-04-17       Impact factor: 6.664
  4 in total
  4 in total

1.  Comparison of day 3 and day 5 thyroglobulin results after thyrogen injection in differentiated thyroid cancer patients.

Authors:  Sait Sager; Esra Hatipoglu; Burcak Gunes; Sertac Asa; Lebriz Uslu; Kerim Sönmezoğlu
Journal:  Ther Adv Endocrinol Metab       Date:  2018-04-17       Impact factor: 3.565

2.  Early stimulated thyroglobulin for response prediction after recombinant human thyrotropin-aided radioiodine therapy.

Authors:  Hee Jeong Park; Jung-Joon Min; Hee-Seung Bom; Jahae Kim; Ho-Chun Song; Seong Young Kwon
Journal:  Ann Nucl Med       Date:  2017-07-07       Impact factor: 2.668

3.  Change of Therapeutic Response Classification According to Recombinant Human Thyrotropin-Stimulated Thyroglobulin Measured at Different Time Points in Papillary Thyroid Carcinoma.

Authors:  Jang Bae Moon; Subin Jeon; Ki Seong Park; Su Woong Yoo; Sae-Ryung Kang; Sang-Geon Cho; Jahae Kim; Changho Lee; Ho-Chun Song; Jung-Joon Min; Hee-Seung Bom; Seong Young Kwon
Journal:  Nucl Med Mol Imaging       Date:  2021-04-29

4.  Optimization of serum thyroglobulin measured at different time points for prognostic evaluation in differentiated thyroid carcinoma patients.

Authors:  Pupree Mutsuddy; Subin Jeon; Su Woong Yoo; Yingjie Zhang; Md Sunny Anam Chowdhury; Jahae Kim; Ho-Chun Song; Hee-Seung Bom; Jung-Joon Min; Seong Young Kwon
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.